Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 28, 2017; 23(36): 6705-6714
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6705
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6705
Figure 2 Serum levels of angiotensin-converting enzyme and fibrotic markers in patients with fatty liver and/or habitual alcoholic drinking.
A: Serum angiotensin-converting enzyme (ACE) level; B: Aspartate aminotransferase to platelet index (APRI); C: Fibrosis index based on the four factors (FIB-4), D: Serum Mac-2 binding protein glycosylation isomer (M2BPGi) level in chronic hepatitis B patients with and without fatty liver and/or habitual alcoholic drinking (FL/AL). Serum ACE levels were significantly higher in the patients with FL/AL than those without FL/AL; E: Fibrosis stage-matched comparison showed that this difference in serum ACE levels between with and without FL/AL was prevalently observed in early stages (F0 and F1) of liver fibrosis. Data are means ± SD, bP < 0.01.
- Citation: Noguchi R, Kaji K, Namisaki T, Moriya K, Kitade M, Takeda K, Kawaratani H, Okura Y, Aihara Y, Furukawa M, Mitoro A, Yoshiji H. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B. World J Gastroenterol 2017; 23(36): 6705-6714
- URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6705.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i36.6705